HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

Retatrutide and other new GLP-1 drugs flagged as worth watching

Gokhan Can · Jun 07, 2026 · ♥ 5 reactions · 6 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)
AI summary & key facts

Short comment that new GLP-1 drugs such as retatrutide show large effects on metabolic dysregulation, but the admin would not jump on them yet. No data given.

New glp1 drugs are in the works (retatrutide) that show massive effects against metabolic disregulation. I wouldn't jump on them yet, but worth keeping on the radar

Post on X · David WDavid W on XI'll have A LOT of retatrutide thoughts. But these cardiometabolic improvements are stunning. 40% drop in triglycerides, 20% drop in LDL. 63% drop in hsCRP, 12 point reduction in BP. It's not a stretch to imagine this drug massively reducing death from CVD and CKD all on its own.x.com
#glp1
← newer: JAMA Cardiology trial: vitamin K2 (MK-7) for 2 years slowed older: Vitamin C has not reduced heart attacks or strokes and plaqu →